查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830861

2025年全球快速藥物微生物學檢測市場報告

Pharmaceutical Rapid Microbiology Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，藥品快速微生物檢測市場規模迅速擴張，從2024年的10.1億美元成長到2025年的11.9億美元，複合年成長率達17.8%。這段歷史性時期的成長動力源自於對可靠微生物檢測需求的日益成長、對病人安全的日益重視、藥品生產過程日益複雜、對污染風險的日益擔憂，以及在產品放行過程中微生物檢測應用的日益普及。

預計未來幾年，醫藥快速微生物檢測市場規模將快速成長，到2029年將達到22.6億美元，複合年成長率為17.4%。預測期內的成長可歸因於對快速獲得結果的需求不斷成長、個人化醫療的普及、社會對藥品安全的日益關注、生技藥品和無菌藥品生產的擴大以及先進品管措施的實施力度不斷加大。預計這段時期的主要趨勢包括分子診斷技術的進步、自動化整合、技術主導的即時數據分析、生物感測器的創新以及基於人工智慧的分析技術的進步。

快速藥物微生物檢測是一種先進的方法，用於檢測和測量藥物和製程中的微生物，其速度遠快於傳統的培養為基礎的方法，通常在數小時內而非數天內即可提供結果。這些快速方法有助於加快決策速度，減少產品放行延遲，並透過降低微生物污染風險來加強品管。

藥品快速微生物檢測的主要產品類型包括儀器、試劑和套件以及配件。儀器是專門的實驗室工具，旨在提供準確、高效和標準化的微生物檢測，以確保藥品的安全和品質。所採用的技術多種多樣，包括聚合酵素鏈鎖反應(PCR)、三磷酸Adenosine(ATP) 生物發光、流式細胞技術、酵素結合免疫吸附檢測法(ELISA)、層析法、生物感測器和生物檢測以及電阻微生物學。這些方法用於檢測各種微生物，包括細菌、真菌（酵母和黴菌）、病毒、黴漿菌和內毒素。應用包括原料檢測、進程內檢測、微生物限量檢測、微生物附著量評估、製程用水檢測、環境監測和無菌測試。主要最終用戶包括製藥和生物技術公司、契約製造組織 (CMO)、醫院和診斷實驗室以及研究和學術機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦正對製藥公司造成嚴重衝擊。高利潤率的學名藥製造商尤其容易受到影響，一些公司甚至縮減了低收益藥品的生產。由於關稅導致的專用試劑短缺，生物技術公司正面臨臨床試驗延期。為此，該產業正在印度和歐洲擴大原料藥的生產，增加庫存，並積極遊說獲得基本藥物的貿易豁免。

《製藥快速微生物檢測市場》研究報告是商業研究公司最新報告系列的一部分，該系列提供製藥快速微生物檢測市場統計數據，例如全球市場規模、區域佔有率、競爭對手的市場佔有率、詳細的製藥快速微生物檢測市場細分、市場趨勢以及製藥快速微生物檢測行業的商機。本《製藥快速微生物檢測市場》研究報告對產業現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

個人化醫療日益受到重視，預計將在未來幾年推動藥物快速微生物學檢測市場的擴張。個人化醫療根據個人的基因特徵、生活方式和環境因素來客製化醫療保健決策和治療。由於對更安全、更有效的標靶治療的需求不斷成長，這種方法變得越來越突出，這些治療可以最大限度地減少治療選擇中的試驗。快速藥物微生物學檢測在支持個人化醫療方面發揮關鍵作用，它能夠快速檢測微生物污染物，確保客製化治療方法的無菌性和安全性。例如，2024 年 2 月，美國非營利組織個人化醫療聯盟報告稱，FDA 在 2023 年核准了16 種針對罕見疾病患者的新型個人化治療方法，而 2022 年則批准了 6 種。因此，對個人化醫療的日益關注正在推動對快速藥物微生物學檢測的需求。

製藥快速微生物檢測市場的公司也在尋求創新解決方案，例如三Adenosine腺苷 (ATP) 生物發光，以加速產品發布，同時確保法規遵循。 ATP 生物發光是一種快速檢測技術，它透過基於螢光素酶的光反應測量 ATP 水平來檢測活微生物，光強度與藥物、醫療設備和相關產品的微生物污染水平相對應。例如，2025 年 3 月，美國健康公司 Nelson Labs LLC 宣布推出快速無菌測試服務。這種新方法提供了更快的檢測、自動化分析和高通量測試能力。透過在不影響合規性的前提下顯著縮短測試時間，該服務支援各種製藥和醫療設備產品，從而實現更快、更可靠的產品發布。

2025年1月，總部位於英國的醫療設備和藥品檢測服務提供者Cormica Limited收購了Focus Laboratories, Inc.，收購金額未揭露。此次收購鞏固了Cormica在實驗室檢測領域的地位，並擴展了其產品組合，為製藥和醫療保健客戶提供先進的檢測解決方案。 Focus Laboratories, Inc.是一家總部位於美國的製藥公司，專注於藥品的快速微生物檢測。

醫藥快速微生物檢測市場由提供微生物污染檢測、鑑定、計數和無菌檢測等服務的公司所獲得的收益組成。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。醫藥快速微生物檢測市場還包括快速無菌檢測套組、內毒素檢測套件、微生物附著量檢測系統、環境監測工具和分子檢測套組的銷售。該市場的價值是“出廠價”，即產品製造商或創造者銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球製藥快速微生物學檢測：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球快速藥物微生物學檢測市場：成長率分析
  • 全球醫藥快速微生物檢測市場表現：規模與成長，2019-2024
  • 全球製藥快速微生物檢測市場預測：規模與成長，2024-2029年，2034年
  • 全球快速藥物微生物學檢測：總目標市場（TAM）

第6章 市場細分

  • 全球醫藥快速微生物檢測市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑和套件
  • 配件
  • 全球醫藥快速微生物檢測市場：按技術類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應（PCR）
  • Adenosine腺苷（ATP）生物發光
  • 流式細胞技術
  • 酵素免疫分析法（ELISA）
  • 層析法
  • 生物感測器和生物檢測
  • 電阻微生物學
  • 其他類型的技術
  • 全球醫藥快速微生物檢測市場：2019-2024年、2024-2029年、2034年
  • 細菌
  • 真菌（酵母和黴菌）
  • 病毒
  • 黴漿菌
  • 內毒素
  • 全球醫藥快速微生物檢測市場：應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 原料檢測
  • 進程內測試
  • 微生物極限測試
  • 微生物附著量評估
  • 製程用水測試
  • 環境監測
  • 無菌測試
  • 全球醫藥快速微生物檢測市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 製藥和生物技術公司
  • 契約製造組織（CMO）
  • 醫院和診斷實驗室
  • 研究和學術機構
  • 全球醫藥快速微生物檢測市場：依儀器類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • Adenosine腺苷（ATP）生物發光儀
  • 流式細胞儀
  • 聚合酵素鏈鎖反應(PCR)熱迴圈儀或即時聚合酵素鏈鎖反應(PCR) 系統
  • 自動化微生物檢測系統
  • 快速免疫檢測裝置
  • 全球醫藥快速微生物檢測市場：按試劑和套件（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
  • Adenosine腺苷（ATP）檢測套件
  • 聚合酵素鏈鎖反應(PCR) 試劑
  • 酵素免疫分析法(ELISA)套件
  • 微生物培養基套件
  • 螢光染色試劑套件
  • 全球醫藥快速微生物檢測市場：依附件（類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 微孔盤或試管
  • 移液管和吸頭
  • 過濾器和薄膜
  • 樣本採集拭子

第7章 區域和國家分析

  • 全球醫藥快速微生物檢測市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球醫藥快速微生物檢測市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 製藥快速微生物檢測市場：競爭格局
  • 製藥快速微生物學檢測市場：公司簡介
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • SGS SA Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • ALS Limited
  • WESSLING GmbH
  • Nelson Labs LLC
  • Labor LS SE & Co. KG
  • GBA Pharma GmbH
  • ANACON LABORATORIES PRIVATE LIMITED
  • Vimta Labs Limited
  • Pacific Biolabs Inc.
  • Wickham Laboratories
  • Microchem Laboratory Inc.
  • Infinity Laboratories Private Limited
  • Ghaziabad Testing Laboratories Private Limited
  • Medistri SA
  • PREWEL LABS PRIVATE LIMITED
  • TUV SUD SOUTH ASIA PRIVATE LIMITED

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年製藥快速微生物檢測市場：提供新機會的國家
  • 2029年製藥快速微生物檢測市場：細分市場帶來新機會
  • 2029年製藥快速微生物檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37852

Pharmaceutical rapid microbiology testing refers to advanced methods that detect and measure microorganisms in pharmaceutical products and processes much faster than traditional culture-based techniques, often providing results within hours instead of days. These rapid methods strengthen quality control by supporting faster decision-making, reducing product release delays, and lowering the risk of microbial contamination.

The main product categories in pharmaceutical rapid microbiology testing include instruments, reagents and kits, and accessories. Instruments are specialized laboratory tools designed to deliver accurate, efficient, and standardized microbiological testing to ensure pharmaceutical product safety and quality. A range of technologies is employed, including polymerase chain reaction (PCR), adenosine triphosphate (ATP) bioluminescence, flow cytometry, enzyme-linked immunosorbent assay (ELISA), chromatography, biosensors and bioassays, impedance microbiology, and others. These methods are used to test various microorganisms, such as bacteria, fungi (yeast and mold), viruses, mycoplasma, and endotoxins. Applications include raw material testing, in-process testing, microbial limit testing, bioburden assessment, process water testing, environmental monitoring, and sterility testing. The primary end users are pharmaceutical and biotechnology companies, contract manufacturing organizations (CMOs), hospitals and diagnostic laboratories, and research and academic institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The pharmaceutical rapid microbiology testing market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical rapid microbiology testing market statistics, including pharmaceutical rapid microbiology testing industry global market size, regional shares, competitors with a pharmaceutical rapid microbiology testing market share, detailed pharmaceutical rapid microbiology testing market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical rapid microbiology testing industry. This pharmaceutical rapid microbiology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical rapid microbiology testing market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.19 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth during the historic period can be attributed to the rising need for reliable microbial detection, an increasing focus on patient safety, the growing complexity of pharmaceutical manufacturing, heightened concerns over contamination risks, and the expanded adoption of microbiology testing in product release processes.

The pharmaceutical rapid microbiology testing market size is expected to see rapid growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to the rising demand for faster results, increasing adoption of personalized medicine, growing public concerns about pharmaceutical safety, expanding production of biologics and sterile drugs, and greater implementation of advanced quality control measures. Key trends expected during this period include advancements in molecular diagnostics, the integration of automation, technology-driven real-time data analysis, innovations in biosensors, and progress in artificial intelligence-based analytics.

The growing emphasis on personalized medicine is expected to drive the expansion of the pharmaceutical rapid microbiology testing market in the coming years. Personalized medicine tailors healthcare decisions and treatments to an individual's genetic profile, lifestyle, and environmental factors. This approach is becoming more prominent due to the rising demand for safer, more effective, and targeted therapies that minimize trial-and-error in treatment selection. Pharmaceutical rapid microbiology testing plays a critical role in supporting personalized medicine by enabling faster detection of microbial contaminants, thereby ensuring the sterility and safety of customized therapies. For instance, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, compared with six in 2022. Therefore, the growing focus on personalized medicine is fueling the demand for pharmaceutical rapid microbiology testing.

Companies in the pharmaceutical rapid microbiology testing market are also advancing innovative solutions such as adenosine triphosphate (ATP) bioluminescence to accelerate product release while ensuring regulatory compliance. ATP bioluminescence is a rapid testing technique that detects live microorganisms by measuring ATP levels through a luciferase-based light reaction, with light intensity corresponding to microbial contamination levels in pharmaceuticals, medical devices, and related products. For example, in March 2025, Nelson Labs LLC, a US-based health company, introduced a rapid-method sterility testing service. This new approach provides faster detection, automated analysis, and high-throughput testing capabilities. By significantly reducing testing times without compromising compliance, the service supports a wide range of pharmaceutical and medical device products, enabling quicker and more reliable product release.

In January 2025, Cormica Ltd., a UK-based provider of medical device and pharmaceutical testing services, acquired Focus Laboratories Inc. for an undisclosed amount. The acquisition strengthens Cormica's position in the laboratory testing sector and expands its portfolio with advanced testing solutions for pharmaceutical and healthcare clients. Focus Laboratories Inc., a US-based pharmaceutical company, specializes in rapid microbiology testing for pharmaceuticals.

Major players in the pharmaceutical rapid microbiology testing market are Merck KGaA, Becton, Dickinson and Company, SGS SA, Eurofins Scientific SE, Charles River Laboratories International Inc, ALS Limited, WESSLING GmbH, Nelson Labs LLC, Labor LS SE & Co. KG, GBA Pharma GmbH, ANACON LABORATORIES PRIVATE LIMITED, Vimta Labs Limited, Pacific Biolabs Inc., Wickham Laboratories, Microchem Laboratory Inc., Infinity Laboratories Private Limited, Ghaziabad Testing Laboratories Private Limited, Medistri SA, PREWEL LABS PRIVATE LIMITED, TUV SUD SOUTH ASIA PRIVATE LIMITED.

North America was the largest region in the pharmaceutical rapid microbiology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical rapid microbiology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical rapid microbiology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical rapid microbiology testing market consists of revenues earned by entities providing services such as microbial contamination detection, identification and enumeration, and sterility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical rapid microbiology testing market also includes sales of rapid sterility testing kits, endotoxin detection kits, bioburden testing systems, environmental monitoring tools and molecular testing kits. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Rapid Microbiology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical rapid microbiology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical rapid microbiology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical rapid microbiology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instruments; Reagents And Kits; Accessories
  • 2) By Technology Type: Polymerase Chain Reaction (PCR); Adenosine Triphosphate (ATP) Bioluminescence; Flow Cytometry; Enzyme-Linked Immunosorbent Assay (ELISA)Chromatography; Biosensors And Bioassays; Impedance Microbiology; Other Technology Types
  • 3) By Microorganism Type Tested: Bacteria; Fungi (Yeast And Mold); Viruses; Mycoplasma; Endotoxins
  • 4) By Application: Raw Material Testing; In-Process Testing; Microbial Limit Testing; Bioburden Assessment; Process Water Testing; Environment Monitoring; Sterility Testing
  • 5) By End-User: Pharmaceutical And Biotechnology Companies; Contract Manufacturing Organizations (CMOs); Hospitals And Diagnostic Laboratories; Research And Academic Institutes
  • Subsegments:
  • 1) By Instruments: Adenosine Triphosphate (ATP) Bioluminometer; Flow Cytometer; Polymerase Chain Reaction (PCR) Thermocycler Or Real-Time Polymerase Chain Reaction (PCR) System; Automated Microbial Detection Systems; Rapid Immunoassay Analyzers
  • 2) By Reagents And Kits: Adenosine Triphosphate (ATP) Detection Kits; Polymerase Chain Reaction (PCR) Reagents; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Microbial Culture Media Kits; Fluorescent Staining Kits
  • 3) By Accessories: Microplates Or Test Tubes; Pipettes And Tips; Filters And Membranes; Sample Collection Swabs
  • Companies Mentioned: Merck KGaA; Becton, Dickinson and Company; SGS SA; Eurofins Scientific SE; Charles River Laboratories International Inc; ALS Limited; WESSLING GmbH; Nelson Labs LLC; Labor LS SE & Co. KG; GBA Pharma GmbH; ANACON LABORATORIES PRIVATE LIMITED; Vimta Labs Limited; Pacific Biolabs Inc.; Wickham Laboratories; Microchem Laboratory Inc.; Infinity Laboratories Private Limited; Ghaziabad Testing Laboratories Private Limited; Medistri SA; PREWEL LABS PRIVATE LIMITED; TUV SUD SOUTH ASIA PRIVATE LIMITED
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Rapid Microbiology Testing Market Characteristics

3. Pharmaceutical Rapid Microbiology Testing Market Trends And Strategies

4. Pharmaceutical Rapid Microbiology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pharmaceutical Rapid Microbiology Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pharmaceutical Rapid Microbiology Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pharmaceutical Rapid Microbiology Testing Market Growth Rate Analysis
  • 5.4. Global Pharmaceutical Rapid Microbiology Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pharmaceutical Rapid Microbiology Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pharmaceutical Rapid Microbiology Testing Total Addressable Market (TAM)

6. Pharmaceutical Rapid Microbiology Testing Market Segmentation

  • 6.1. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Kits
  • Accessories
  • 6.2. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • Adenosine Triphosphate (ATP) Bioluminescence
  • Flow Cytometry
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Chromatography
  • Biosensors And Bioassays
  • Impedance Microbiology
  • Other Technology Types
  • 6.3. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacteria
  • Fungi (Yeast And Mold)
  • Viruses
  • Mycoplasma
  • Endotoxins
  • 6.4. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Raw Material Testing
  • In-Process Testing
  • Microbial Limit Testing
  • Bioburden Assessment
  • Process Water Testing
  • Environment Monitoring
  • Sterility Testing
  • 6.5. Global Pharmaceutical Rapid Microbiology Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Contract Manufacturing Organizations (CMOs)
  • Hospitals And Diagnostic Laboratories
  • Research And Academic Institutes
  • 6.6. Global Pharmaceutical Rapid Microbiology Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenosine Triphosphate (ATP) Bioluminometer
  • Flow Cytometer
  • Polymerase Chain Reaction (PCR) Thermocycler Or Real-Time Polymerase Chain Reaction (PCR) System
  • Automated Microbial Detection Systems
  • Rapid Immunoassay Analyzers
  • 6.7. Global Pharmaceutical Rapid Microbiology Testing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adenosine Triphosphate (ATP) Detection Kits
  • Polymerase Chain Reaction (PCR) Reagents
  • Enzyme-Linked Immunosorbent Assay (ELISA) Kits
  • Microbial Culture Media Kits
  • Fluorescent Staining Kits
  • 6.8. Global Pharmaceutical Rapid Microbiology Testing Market, Sub-Segmentation Of Accessories, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microplates Or Test Tubes
  • Pipettes And Tips
  • Filters And Membranes
  • Sample Collection Swabs

7. Pharmaceutical Rapid Microbiology Testing Market Regional And Country Analysis

  • 7.1. Global Pharmaceutical Rapid Microbiology Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pharmaceutical Rapid Microbiology Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market

  • 8.1. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceutical Rapid Microbiology Testing Market

  • 9.1. China Pharmaceutical Rapid Microbiology Testing Market Overview
  • 9.2. China Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceutical Rapid Microbiology Testing Market

  • 10.1. India Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceutical Rapid Microbiology Testing Market

  • 11.1. Japan Pharmaceutical Rapid Microbiology Testing Market Overview
  • 11.2. Japan Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceutical Rapid Microbiology Testing Market

  • 12.1. Australia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceutical Rapid Microbiology Testing Market

  • 13.1. Indonesia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceutical Rapid Microbiology Testing Market

  • 14.1. South Korea Pharmaceutical Rapid Microbiology Testing Market Overview
  • 14.2. South Korea Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceutical Rapid Microbiology Testing Market

  • 15.1. Western Europe Pharmaceutical Rapid Microbiology Testing Market Overview
  • 15.2. Western Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceutical Rapid Microbiology Testing Market

  • 16.1. UK Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceutical Rapid Microbiology Testing Market

  • 17.1. Germany Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceutical Rapid Microbiology Testing Market

  • 18.1. France Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceutical Rapid Microbiology Testing Market

  • 19.1. Italy Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceutical Rapid Microbiology Testing Market

  • 20.1. Spain Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market

  • 21.1. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market Overview
  • 21.2. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceutical Rapid Microbiology Testing Market

  • 22.1. Russia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceutical Rapid Microbiology Testing Market

  • 23.1. North America Pharmaceutical Rapid Microbiology Testing Market Overview
  • 23.2. North America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceutical Rapid Microbiology Testing Market

  • 24.1. USA Pharmaceutical Rapid Microbiology Testing Market Overview
  • 24.2. USA Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceutical Rapid Microbiology Testing Market

  • 25.1. Canada Pharmaceutical Rapid Microbiology Testing Market Overview
  • 25.2. Canada Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceutical Rapid Microbiology Testing Market

  • 26.1. South America Pharmaceutical Rapid Microbiology Testing Market Overview
  • 26.2. South America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceutical Rapid Microbiology Testing Market

  • 27.1. Brazil Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceutical Rapid Microbiology Testing Market

  • 28.1. Middle East Pharmaceutical Rapid Microbiology Testing Market Overview
  • 28.2. Middle East Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceutical Rapid Microbiology Testing Market

  • 29.1. Africa Pharmaceutical Rapid Microbiology Testing Market Overview
  • 29.2. Africa Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pharmaceutical Rapid Microbiology Testing Market, Segmentation By Microorganism Type Tested, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceutical Rapid Microbiology Testing Market Competitive Landscape And Company Profiles

  • 30.1. Pharmaceutical Rapid Microbiology Testing Market Competitive Landscape
  • 30.2. Pharmaceutical Rapid Microbiology Testing Market Company Profiles
    • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. SGS SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles River Laboratories International Inc Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceutical Rapid Microbiology Testing Market Other Major And Innovative Companies

  • 31.1. ALS Limited
  • 31.2. WESSLING GmbH
  • 31.3. Nelson Labs LLC
  • 31.4. Labor LS SE & Co. KG
  • 31.5. GBA Pharma GmbH
  • 31.6. ANACON LABORATORIES PRIVATE LIMITED
  • 31.7. Vimta Labs Limited
  • 31.8. Pacific Biolabs Inc.
  • 31.9. Wickham Laboratories
  • 31.10. Microchem Laboratory Inc.
  • 31.11. Infinity Laboratories Private Limited
  • 31.12. Ghaziabad Testing Laboratories Private Limited
  • 31.13. Medistri SA
  • 31.14. PREWEL LABS PRIVATE LIMITED
  • 31.15. TUV SUD SOUTH ASIA PRIVATE LIMITED

32. Global Pharmaceutical Rapid Microbiology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceutical Rapid Microbiology Testing Market

34. Recent Developments In The Pharmaceutical Rapid Microbiology Testing Market

35. Pharmaceutical Rapid Microbiology Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Pharmaceutical Rapid Microbiology Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pharmaceutical Rapid Microbiology Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pharmaceutical Rapid Microbiology Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer